Chiropractic Care Options for Gluteus Medius Tendinopathy

Find out how chiropractic care can alleviate the symptoms of gluteus medius tendinopathy for better movement.

Abstract: Understanding Gluteus Medius Tendinopathy and Targeted Injection Therapy

Greater trochanteric pain syndrome (GTPS) represents one of the most commonly encountered yet frequently misdiagnosed conditions in musculoskeletal and primary care medicine. Affecting millions of individuals worldwide, this condition is characterized by lateral hip pain that localizes to the region of the greater trochanter — a bony prominence on the proximal femur that serves as the insertion site for several critical hip abductor tendons, most notably the gluteus medius and gluteus minimus. For decades, clinicians broadly and imprecisely labeled this condition as “trochanteric bursitis,” a term that implied the trochanteric bursa was the primary pain generator. However, modern imaging studies and histopathological research have fundamentally revised our understanding of this syndrome. Contemporary evidence strongly implicates gluteus medius tendinopathy — a degenerative process within the tendon fibers themselves — as the predominant pathological driver in the majority of patients presenting with lateral hip pain.

In this educational post, I present a detailed clinical case involving a 57-year-old male patient who arrived at my clinic with a two-month history of left hip pain localized to the posterior and superior aspect of the greater trochanter — a distribution entirely consistent with gluteus medius tendon pathology. Through careful palpation and provocation testing, I reproduced the patient’s chief complaint with precision, confirming the tendon as the primary pain generator and guiding a targeted peritendinous corticosteroid and local anesthetic injection using anatomical landmarks.

This post explores the full spectrum of relevant clinical knowledge surrounding this condition. Beginning with a thorough review of the functional anatomy of the gluteus medius and its tendinous insertion, we will examine the biomechanical forces that predispose this structure to degenerative change. We will discuss the pathophysiology of tendinopathy in depth, distinguishing it from true bursitis and explaining why this distinction matters clinically. We will explore the epidemiology of GTPS, review the most commonly affected populations, and discuss the modifiable and non-modifiable risk factors that increase vulnerability.

We will then examine the clinical assessment strategies used to diagnose gluteus medius tendinopathy, including palpatory provocation testing, special orthopedic maneuvers, and the role of diagnostic imaging — particularly musculoskeletal ultrasound and magnetic resonance imaging (MRI) — in confirming the diagnosis. Next, we will discuss the injection procedure in detail, explaining the rationale for each preparatory and procedural step, the pharmacology of the agents used, and the expected patient response. Finally, we will address the broader context of multimodal rehabilitation, including exercise-based tendon loading protocols, biomechanical correction, and the role of emerging regenerative therapies such as platelet-rich plasma (PRP) in refractory cases.

By the end of this post, readers will have a comprehensive, evidence-based understanding of gluteus medius tendinopathy—from its microscopic pathology to its clinical management—grounded in the latest findings from leading researchers in the field.

The Anatomy of the Greater Trochanter and Gluteus Medius: A Foundation for Clinical Understanding

To fully appreciate gluteus medius tendinopathy, it is essential to first understand the regional anatomy. The greater trochanter is a large, quadrilateral bony prominence located at the proximal lateral aspect of the femur. It serves as a critical mechanical anchor point for the hip abductor musculature and plays a central role in stabilizing the pelvis during gait and single-limb stance activities.

The greater trochanter is not a single flat surface but a complex three-dimensional structure composed of four distinct facets: anterior, lateral, superoposterior, and posterior. Each facet provides an attachment site for specific tendinous structures. Understanding this multifaceted architecture is essential because different tendon insertions are associated with different pathology patterns, and the superoposterior and posterior facets are most closely associated with gluteus medius tendon degeneration, the area directly implicated in the case presented here.

The Gluteus Medius Muscle: Structure, Fiber Composition, and Functional Role

The gluteus medius is a large, fan-shaped muscle that arises from the outer surface of the ilium, between the anterior and posterior gluteal lines. Its fibers converge to form a strong, flat tendon that inserts primarily onto the superoposterior and lateral facets of the greater trochanter. The muscle belly has two functionally distinct regions: anterior fibers, oriented more horizontally and contributing primarily to hip abduction and internal rotation, and posterior fibers, more obliquely oriented and contributing to hip abduction and external rotation.

The gluteus medius is the primary hip abductor and is critical for pelvic stability during walking, running, and any single-limb weight-bearing activity. During the stance phase of gait, the gluteus medius contracts eccentrically and concentrically to prevent the contralateral pelvis from dropping — a mechanism known as the Trendelenburg mechanism. Without adequate gluteus medius strength and neuromuscular coordination, the pelvis tilts toward the unsupported side (a positive Trendelenburg sign), creating a cascade of compensatory biomechanical changes throughout the lower extremity chain that significantly increase compressive and tensile loads on the tendon at its trochanteric insertion.

The gluteus medius tendon is composed predominantly of type I collagen fibers arranged in a parallel, hierarchical structure that provides tensile strength and some elasticity. This collagen architecture allows the tendon to store and release elastic energy efficiently during repetitive loading activities. However, this same architecture also makes the tendon vulnerable to cumulative microtrauma when loading exceeds its adaptive capacity—a process that, over time, leads to the degenerative changes characteristic of tendinopathy.

The Gluteus Minimus and Its Relationship to Gluteus Medius Pathology

Immediately deep to the gluteus medius lies the gluteus minimus, a smaller but functionally related muscle that originates from the outer ilium between the anterior and inferior gluteal lines. The gluteus minimus tendon inserts onto the anterior facet of the greater trochanter and contributes to hip abduction and internal rotation. In many patients with gluteus medius tendinopathy, the gluteus minimus tendon is simultaneously involved, particularly in more severe or chronic cases. Imaging studies have demonstrated co-existing gluteus minimus tendon pathology in a significant proportion of patients with lateral hip pain, reinforcing the concept of GTPS as a spectrum of tendinous disease rather than an isolated structural lesion.

The Trochanteric Bursae: Anatomy and Clinical Relevance

Three bursae are consistently identified in the region of the greater trochanter: the subgluteus maximus bursa (the largest and most clinically significant, positioned between the gluteus maximus and the greater trochanter), the subgluteus medius bursa (located between the gluteus medius tendon and the superoposterior facet), and the subgluteus minimus bursa (positioned deep to the gluteus minimus tendon at the anterior facet).

For many years, it was assumed that primary inflammation of the subgluteus maximus bursa (often called the “trochanteric bursa”) was responsible for the lateral hip pain syndrome now recognized as GTPS. This assumption led to the widespread use of the term “trochanteric bursitis” and, consequently, to injection strategies that targeted the bursal space rather than the tendon. However, landmark histopathological studies — most notably the work of Connell et al. (2003) and subsequent research by Fearon et al. (2012) — demonstrated conclusively that primary bursitis is rarely the dominant pathology in this syndrome. Instead, the tendon itself shows degenerative changes, and bursal distension, when present, is typically secondary to adjacent tendon pathology rather than a primary inflammatory process.

This distinction has profound implications for treatment targeting, injection technique, and rehabilitation design — all of which will be discussed in detail in subsequent sections of this post.

The Pathophysiology of Gluteus Medius Tendinopathy: From Microtrauma to Degenerative Change

Understanding why and how the gluteus medius tendon degenerates requires a thorough appreciation of tendinopathy’s biology —a field transformed by modern research over the past three decades. The traditional view of tendon pain as purely inflammatory has been replaced by a model that recognizes tendinopathy as a failed healing response to cumulative mechanical overload, driven by a complex interplay of cellular, biochemical, and structural changes within the tendon matrix.

The Continuum Model of Tendinopathy

The most widely accepted contemporary framework for understanding tendinopathy is the continuum model proposed by Cook and Purdam (2009), which describes a spectrum of tendon pathology ranging from reactive tendinopathy at one end to degenerative tendinopathy at the other, with tendon dysrepair as an intermediate stage.

Reactive tendinopathy represents the earliest stage of pathological change. It occurs in response to an acute overload of the tendon — either a sudden increase in mechanical loading or an episode of direct compression — and is characterized by a non-inflammatory cellular response in which tenocytes (the resident cells of the tendon) proliferate and upregulate the production of proteoglycans and water-binding molecules. This response increases the tendon’s cross-sectional area, effectively reducing stress per unit area, but it also disrupts the orderly collagen architecture. At this stage, the pathological changes may be fully reversible if provocative loading is appropriately modified.

If the overloading stimulus persists without adequate recovery, the tendon progresses to the dysrepair stage, characterized by increased matrix disorganization, ingrowth of new blood vessels (neovascularization), and increased substance P and other neuropeptides that sensitize local nerve endings and contribute to pain. The tenocyte population undergoes phenotypic changes, adopting characteristics more similar to chondrocytes and fibroblasts, and begins producing type III collagen — a less mechanically robust form — alongside the normal type I collagen. This disruption of the normal collagen ratio weakens the tendon structurally.

Degenerative tendinopathy represents the most advanced stage of the continuum. It is characterized by large areas of matrix disorganization, cell death (both apoptotic and necrotic), lipid deposits, calcification, and neovascular ingrowth accompanied by nerve fiber proliferation. These neovessels and associated nerves — which appear to track together in what researchers have termed neurovascular ingrowth — are believed to be a significant source of the chronic pain experienced in degenerative tendinopathy. At this stage, the tendon’s structural integrity is significantly compromised, and the changes may be largely irreversible, though symptom management and functional improvement remain achievable goals.

Compressive Loads: A Unique Feature of Insertional Tendinopathy

The gluteus medius tendon, as an insertional tendon — one that attaches directly to bone — is subject to a distinctive form of mechanical stress not experienced by midsubstance tendons. In addition to the tensile loads generated by muscle contraction, insertional tendons are subjected to compressive loads when the adjacent bony surface makes contact with the tendon, particularly in positions of hip adduction or combined adduction and flexion.

Research by Cook, Purdam, and colleagues has demonstrated that compressive loading is a particularly potent driver of tendinopathy at insertional sites. Compression disrupts the normal parallel alignment of collagen fibers and promotes the chondroid metaplasia characteristic of degenerative tendinopathy. For the gluteus medius tendon, compressive loading occurs primarily when the hip is adducted across the midline — for example, during cross-legged sitting, standing with weight shifted onto one hip (hip hanging posture), sleeping on the affected side, or activities that involve repeated hip adduction such as running with a narrow stride width.

This understanding of compressive loading has critically informed rehabilitation protocols for gluteus medius tendinopathy, which now incorporate strategies to avoid provocative compressive positions during the early stages of treatment. We will elaborate on this principle in the rehabilitation section of this post.

Neovascularization and Neurochemical Sensitization in Chronic Tendinopathy

One of the most significant advances in our understanding of tendinopathy pain is the recognition that neovascularization—the ingrowth of new, structurally immature blood vessels into areas of tendon degeneration—is accompanied by the proliferation of sensory and sympathetic nerve fibers. These ingrowing nerve fibers express receptors for pain-producing substances such as substance P, glutamate, and calcitonin gene-related peptide (CGRP), creating a local neurochemical environment that promotes both peripheral and central sensitization.

Alfredson and colleagues pioneered the use of Doppler ultrasound to visualize these neovessels in symptomatic tendons, demonstrating a consistent relationship between neovascular flow and pain in conditions such as Achilles tendinopathy and patellar tendinopathy. Although gluteus medius tendinopathy has been less extensively studied by Doppler than these other tendons, the underlying neurobiological mechanisms are believed to be similar. The presence of these sensitized nerve fibers helps explain why even relatively gentle palpation over the gluteus medius tendon insertion can reproduce the patient’s pain with high specificity — as was clearly demonstrated in the clinical case described in this post.

Epidemiology and Risk Factors: Who Gets Gluteus Medius Tendinopathy?

Greater trochanteric pain syndrome, driven predominantly by gluteus medius tendinopathy, is one of the most prevalent musculoskeletal conditions in the general population. Epidemiological data suggest a prevalence of about 1.8 per 1,000 persons per year in adults, with rates rising substantially with age. The condition has traditionally been regarded as more common in women, with a female-to-male ratio of approximately 3:1 to 4:1 reported in several large clinical series. This sex disparity has been attributed to differences in pelvic geometry — women have a wider pelvis relative to femoral head spacing (a greater Q-angle and neck-shaft angle), which increases the valgus vector at the hip and amplifies compressive loads on the lateral trochanteric tendons.

However, the case presented here involves a 57-year-old male patient, consistent with epidemiological data showing that GTPS is not rare in men, particularly as they enter middle age and beyond. In men, the condition is often associated with degenerative changes in adjacent structures, prior hip pathology, or significant occupational or recreational physical demands.

Age and Degenerative Change

Age is perhaps the single most significant non-modifiable risk factor for gluteus medius tendinopathy. As age advances, tendon tissue undergoes well-documented degenerative changes, including decreased cellularity, reduced proteoglycan content, increased cross-linking of collagen fibers (paradoxically reducing both elasticity and fatigue resistance), and diminished vascularity in the tendon proper. These age-related changes reduce the tendon’s capacity to adapt to mechanical loading and repair microtrauma, predisposing it to the degenerative cascade described above.

The fact that our patient is 57 years old places him squarely in the age range of highest clinical incidence for this condition. At this age, decades of cumulative mechanical loading and declining tendon regenerative capacity converge to create optimal conditions for symptomatic tendinopathy.

Body Mass Index and Metabolic Factors

Elevated body mass index (BMI) is a well-established risk factor for GTPS. Increased body weight directly amplifies the compressive and tensile loads on the hip abductor tendons during weight-bearing activities. Moreover, research increasingly shows that adipose tissue is not merely a passive mechanical load but an active endocrine organ that secretes pro-inflammatory cytokines—including tumor necrosis factor-alpha (TNF-?), interleukin-6 (IL-6), and leptin—that may directly impair tendon healing and promote degenerative change.

Related metabolic conditions, including type 2 diabetes mellitus, dyslipidemia, and metabolic syndrome, have similarly been associated with increased prevalence and severity of tendinopathy across multiple anatomical sites. These metabolic factors appear to impair tenocytes’ normal remodeling response to mechanical loading, shifting the balance away from matrix synthesis and toward matrix degradation.

Biomechanical and Activity-Related Risk Factors

From a biomechanical perspective, several factors increase the risk of gluteus medius tendinopathy by elevating compressive or tensile loads on the tendon. Hip adduction postures, as described above, are particularly implicated. In the standing individual, habitual hip-hanging — a posture in which body weight is shifted entirely onto one hip, causing the pelvis to drop on the opposite side — creates sustained compressive loading of the ipsilateral gluteus medius tendon insertion and is a common finding in patients with GTPS.

Running biomechanics are also highly relevant. Runners who demonstrate excessive contralateral pelvic drop (a marker of gluteus medius weakness or inhibition), ipsilateral trunk lean (a compensatory pattern that further loads the tendon), or a narrow step width (which forces the hip into adduction with each footfall) are at substantially elevated risk. Research by Noehren, Hamill, and colleagues has demonstrated clear associations between these kinematic patterns and the development of lateral hip pain in runners.

Lumbar spine pathology deserves specific mention as a contributing factor. The gluteus medius is innervated by the superior gluteal nerve (L4, L5, S1), and radiculopathy or peripheral nerve entrapment at these levels can cause neurogenic inhibition of the gluteus medius, reducing its ability to generate force and leaving the tendon’s attachment site mechanically vulnerable. Therefore, when evaluating any patient with lateral hip pain, it is essential to assess the lumbar spine and rule out referred pain from spinal pathology as a contributing or confounding factor.

Clinical Presentation and Diagnostic Assessment of Gluteus Medius Tendinopathy

The clinical presentation of gluteus medius tendinopathy is sufficiently characteristic that an experienced clinician can typically arrive at a working diagnosis through history and physical examination alone, with imaging studies serving primarily to confirm the diagnosis and assess severity.

History and Pain Characterization

Patients typically report deep, aching lateral hip pain localized to the greater trochanter region. Patients often describe the pain as located “on the outside of the hip bone” or “in the hip itself,” and they frequently point directly to the greater trochanter when asked to localize their discomfort. As demonstrated in the clinical case presented here, our patient’s pain was specifically located in the posterior and superior aspect of the greater trochanter—the region corresponding to the superoposterior facet, where the gluteus medius tendon inserts.

The pain characteristically worsens with activities that load the hip abductors — including walking, stair climbing, running, and prolonged standing — and is aggravated by positions of hip adduction and compression, such as lying on the affected side at night (a very common complaint that significantly disrupts sleep quality), sitting with legs crossed, or sitting in low chairs that flex the hip beyond approximately 90 degrees. Pain that is exclusively nocturnal and related to lying on the side should prompt specific inquiry about sleep positioning, as it is both a diagnostic clue and a target for behavioral modification.

The duration of symptoms in our patient — two months — is clinically significant. This timeframe suggests the tendon pathology has likely progressed beyond the acute reactive stage and may be in the dysrepair or early degenerative phase of the tendinopathy continuum, making it responsive to targeted injection therapy and structured rehabilitation rather than activity modification alone.

Physical Examination: Palpatory Assessment

The cornerstone of the physical examination for gluteus medius tendinopathy is palpationally provoking the greater trochanter and surrounding structures. A systematic palpation approach should include the anterior, lateral, superoposterior, and posterior facets of the greater trochanter, as well as the gluteus medius muscle belly proximal to the tendon.

As the clinical case clearly demonstrates, precise reproduction of the patient’s chief complaint through palpation over the gluteus medius tendon insertion is the most important physical examination finding for confirming the diagnosis. The landmark study by Lievense et al. (2005) showed that point tenderness over the greater trochanter has a sensitivity of about 76% and a specificity of about 89% for GTPS, making it one of the more reliable findings in musculoskeletal examination.

The examiner should note not only whether palpation reproduces pain but also the quality of the tissue beneath the fingertips. In healthy tendon tissue, the gluteus medius tendon feels firm, smooth, and well-defined. In tendinopathy, the tendon may feel thickened, nodular, or irregular, and the patient may subjectively sense increased tissue tension in the area.

Special Orthopedic Tests for Gluteus Medius Tendinopathy

Several specific orthopedic tests have been developed and validated to assess GTPS and gluteus medius tendinopathy.

The FABER Test (Flexion, ABduction, External Rotation) places the hip in a position that stretches the posterior capsule and external rotators and loads the gluteus medius tendon in a tensile fashion. A positive test reproduces lateral hip pain and suggests involvement of the hip abductor tendons or the hip joint itself.

The FADIR Test (Flexion, ADduction, Internal Rotation) places the hip in a position of maximum compressive loading on the lateral trochanteric tendons. A strongly positive FADIR test that reproduces lateral trochanteric pain strongly suggests gluteus medius or minimus tendinopathy, as this position places the tendon under maximum compressive stress against the greater trochanter.

The Single-Leg Stance Test (Modified Trendelenburg) assesses the gluteus medius’s functional capacity to stabilize the pelvis. The patient stands on the affected limb for 30 seconds while the examiner observes for contralateral pelvic drop, ipsilateral trunk lean, or onset of lateral hip pain. Inability to maintain a level pelvis or pain reproduction within 30 seconds indicates a positive test and suggests gluteus medius dysfunction.

The Resisted Hip Abduction Test assesses gluteus medius strength and pain response during active contraction. The examiner applies resistance to hip abduction while the patient lies on their side. Pain reproduction and/or weakness compared with the contralateral side suggest gluteus medius tendinopathy or a partial tear of the gluteus medius tendon.

The 30-Second Single-Leg Stand Test described by Grimaldi and Fearon specifically evaluates for compression-related pain reproduction in GTPS. The patient stands on the symptomatic limb for 30 seconds while maintaining an upright trunk. Reproduction of lateral hip pain within this timeframe, particularly pain that intensifies toward the end of the 30 seconds, is a positive finding for compressive tendinopathy.

Diagnostic Imaging: Musculoskeletal Ultrasound

Musculoskeletal ultrasound (MSK-US) has become the imaging modality of first choice for evaluating and managing gluteus medius tendinopathy, offering several distinct advantages over other imaging techniques. It is readily available, non-ionizing, cost-effective, and—critically—provides real-time, dynamic imaging that lets the clinician visualize the tendon during movement and under provocation, and guide injections with precision that landmark-based techniques alone cannot achieve.

On ultrasound, the normal gluteus medius tendon appears as a hyperechoic (bright), fibrillar structure with a characteristic parallel echogenic pattern. In tendinopathy, characteristic changes include hypoechoic (dark) areas within the tendon substance, representing regions of disorganized collagen and increased water content, thickening of the tendon compared to the contralateral side, surface irregularity at the tendon-bone interface, and — in cases of partial or full-thickness tearing — focal defects or discontinuities within the tendon fibers.

Power Doppler imaging can additionally demonstrate neovascular flow within the tendon — the neovessels described earlier that are associated with the neurochemical pain sensitization characteristic of chronic tendinopathy. The Increasedpler signal within the tendon substance correlates with symptom severity in many patients and may have prognostic and treatment-planning implications.

Ultrasound also allows excellent visualization of the trochanteric bursae, enabling differentiation between primary bursitis (characterized by a well-defined, anechoic fluid collection surrounding the trochanter) and the dry or minimally effused bursa typically seen when tendinopathy is the dominant pathology.

Diagnostic Imaging: Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) offers superior soft-tissue contrast resolution compared with ultrasound. It is the gold-standard imaging modality for comprehensively characterizing the extent and severity of gluteus medius and minimus tendon pathology. MRI is particularly valuable in complex cases where the diagnosis is uncertain, a full-thickness tendon tear is suspected, or concomitant intra-articular pathology (such as hip labral tears or femoroacetabular impingement) needs simultaneous evaluation.

On MRI, gluteus medius tendinopathy appears as increased signal intensity within the tendon on T2-weighted and STIR sequences, reflecting the increased water content associated with matrix disorganization and edema. Full-thickness tears appear as complete signal discontinuity through the tendon, often with retraction of the tendon fibers and muscle atrophy with fatty infiltration of the gluteus medius or minimus. This finding has significant prognostic implications for functional recovery.

Research by Woodley et al. (2008) demonstrated that MRI findings of gluteus medius tendon pathology were present in 100% of patients with clinically diagnosed GTPS in their study cohort, confirming the tendon — rather than the bursa — as the primary pathological structure in this syndrome. This landmark finding has been pivotal in shifting clinical practice away from indiscriminate bursal injections toward tendon-targeted interventions.

The Injection Procedure: Rationale, Technique, and Pharmacological Considerations

Corticosteroid injections in the management of musculoskeletal tendinopathy are among the most widely practiced yet vigorously debated interventional strategies in clinical medicine. Understanding both the rationale for their use and their limitations and risks is essential for any clinician performing these procedures.

Why Perform a Peritendinous Injection for Gluteus Medius Tendinopathy?

The primary rationale for a peritendinous corticosteroid injection in gluteus medius tendinopathy is to rapidly and specifically reduce pain and inflammation in the peritendinous tissues, creating a window of reduced pain in which the patient can engage more effectively in the rehabilitative exercise program that is the cornerstone of long-term management.

A corticosteroid injection is not a curative treatment for tendinopathy. It does not reverse the underlying degenerative changes in the tendon matrix, and without a concurrent, structured rehabilitation program, the symptomatic relief it provides is typically transient. The landmark randomized controlled trial by Rompe et al. (2009) showed that while corticosteroid injection produced greater short-term pain reduction than eccentric exercise or extracorporeal shockwave therapy (ESWT) at 4 weeks, this advantage reversed by 15 weeks, with ESWT and exercise showing better outcomes at longer follow-up. These findings underscore the principle that injection therapy should always be embedded within a comprehensive management plan, not used in isolation.

Physiologically, corticosteroids exert their effects through multiple mechanisms. They suppress prostaglandin and leukotriene production by inhibiting phospholipase A2, reducing the neurochemical milieu of pain-producing substances in the peritendinous region. They also affect nociceptor sensitization, reducing the responsiveness of local sensory nerve fibers to pain-producing stimuli. Additionally, corticosteroids may modulate neovascular proliferation associated with tendinopathy by inhibiting vascular endothelial growth factor (VEGF) signaling, potentially interrupting a key driver of chronic pain in degenerative tendinopathy.

However, corticosteroids also have potentially adverse effects on tendon tissue. In vitro and animal studies have demonstrated that corticosteroids can impair tenocyte viability, reduce collagen synthesis, and weaken tendon mechanical properties when injected directly into the tendon substance. These findings have reinforced the importance of peritendinous (rather than intratendinous) injection technique — injecting around the tendon rather than within it — which is precisely the approach demonstrated in the clinical case presented here.

Anatomy-Guided Versus Ultrasound-Guided Injection: The Case for Precision

The injection in this clinical case was performed using anatomical landmark guidance—a technique that relies on thorough knowledge of regional anatomy and precise palpatory identification of the target structure. With skilled hands, landmark-guided injection at the gluteus medius tendon insertion can achieve acceptable accuracy, especially when provocation testing with the needle tip confirms proximity to the tendon before injection (as demonstrated when the patient confirmed that pressure from the needle tip exactly replicated their pain).

However, it is important to acknowledge that ultrasound-guided injection offers significant advantages in terms of accuracy and safety. Multiple studies have demonstrated that landmark-guided injections of the trochanteric region achieve correct placement in only 40 to 55% of cases in the absence of real-time imaging guidance, with the majority of misplacements occurring either superficially (into subcutaneous fat) or into the bursal space rather than at the tendon insertion. Ultrasound guidance has increased the accuracy of peritendinous injection at the gluteus medius tendon to greater than 90%, reduced procedural pain, and decreased the risk of inadvertent intratendinous injection.

Given these data, point-of-care musculoskeletal ultrasound is the current gold standard for integrating into injection procedures, and its increasing availability in outpatient musculoskeletal clinics has significantly improved the precision and safety of these procedures. I routinely incorporate musculoskeletal ultrasound guidance into my injection practice at HealthVoice360, and its value in complex or previously failed cases cannot be overstated.

Preparation and Aseptic Technique: Why Every Step Matters

The injection procedure demonstrated in this clinical case follows a meticulous aseptic protocol that deserves close examination, as each preparatory step serves a specific purpose in minimizing the risk of iatrogenic infection—a complication that, while rare, carries significant morbidity when it occurs in the periarticular or peritendinous tissues.

The procedure begins with identification and marking of the injection site based on palpatory reproduction of the patient’s pain. This step ensures that the needle is directed toward the anatomically correct target — the gluteus medius tendon insertion at the superoposterior facet of the greater trochanter — rather than toward the bursal space or the subcutaneous tissue.

Alcohol swabbing moves surface organisms (primarily commensal gram-positive bacteria) and dissolves lipid-soluble contaminants. However, alcohol alone is insufficient for comprehensive skin decontamination before an injection procedure.

Povidone-iodine (Betadine) provides broader antimicrobial coverage, with bactericidal activity against gram-positive organisms (including Staphylococcus aureus, the most common pathogen in post-injection infections), gram-negative organisms, fungi, and many viruses. The two-pass application technique demonstrated in the clinical case ensures adequate contact time and complete coverage of the injection site. The iodine must be allowed to dry — typically 30 to 60 seconds — before needle insertion to achieve its maximum antimicrobial effect.

Ethyl chloride spray is used immediately before needle insertion as a topical cryoanesthetic — it achieves rapid superficial anesthesia by lowering the skin temperature, reducing the pain of needle penetration through the dermis. Although it does not reach the tendon, reducing superficial pain significantly improves patient comfort and cooperation during the procedure.

The Injection Technique: Step-by-Step Clinical Analysis

Following skin preparation, the needle is advanced toward the gluteus medius tendon insertion using a direct posterior approach to the superoposterior facet of the greater trochanter. The gluteus medius tendon depth varies with body habitus. Still, in most patients it lies 3 to 6 centimeters deep from the skin surface, within or just deep to the gluteus maximus muscle fascia.

The clinician’s description of feeling the needle enter the tendon — confirmed by a sensation of increased resistance as the needle tip engages the dense collagen matrix of the tendon — is a critical tactile landmark in landmark-guided injection technique. This increased resistance physically correlates with the needle’s interaction with the tendon’s tightly packed collagen fiber bundles, and recognizing it allows the clinician to confirm proximity to the target tissue before injection.

The additional confirmation technique described — asking the assistant to slide their fingers along the syringe barrel to detect increased plunger resistance — provides a secondary tactile indicator of needle placement within or adjacent to the tendon. Dense tendinous tissue offers significantly greater resistance to injection than the surrounding loose areolar tissue or the fluid-filled bursa, and this difference in resistance is palpable during careful injection.

Reproduction of the patient’s pain with injection — as clearly demonstrated in this case, where the patient confirmed that the sensation during injection exactly replicated their chief complaint — is the most reliable confirmation that the needle tip is correctly positioned at the pathological tissue. This provocation response reflects the distension and mechanical stimulation of the sensitized nerve fibers surrounding the degenerative tendon tissue.

The fanning technique — advancing and redirecting the needle in small incremental angles to distribute the injectate across a broader area — is particularly important for the gluteus medius tendon because it is a broad, fan-shaped structure covering a relatively wide area of the greater trochanter. A single deposit at one point within this tendon may cover only a fraction of the pathological area. In contrast, systematic fanning allows the medication to infiltrate the peritendinous space more comprehensively, improving the likelihood of an adequate therapeutic effect.

The Injected Agents: Pharmacology and Clinical Rationale

This clinical injection involves two primary agents: a corticosteroid (the therapeutic agent) and a local anesthetic (which serves as both the vehicle for the corticosteroid and an immediate diagnostic and analgesic agent).

Local anesthetics — most commonly lidocaine (1–2%) or bupivacaine (0.25–0.5%) — act by blocking voltage-gated sodium channels in sensory nerve fibers, preventing the generation and propagation of action potentials. This blocks nociceptive signal transmission from the injection site, providing immediate pain relief that confirms correct needle placement (as demonstrated when post-injection assessment showed reduced tenderness in our patient) and improves patient comfort during and after the procedure. The duration of action varies by agent: lidocaine provides anesthesia for about 1 to 3 hours, while bupivacaine provides longer-lasting anesthesia for 4 to 8 hours.

Corticosteroids used for musculoskeletal injections are typically depot preparations — poorly water-soluble esters that are slowly absorbed from the injection site, providing a prolonged local effect over days to weeks. Commonly used agents include triamcinolone acetonide (40 mg/mL), methylprednisolone acetate (40–80 mg/mL), and betamethasone (3–6 mg). Each agent has a slightly different onset and duration of action, with triamcinolone and betamethasone generally considered the most potent and longest-acting options for peritendinous injection.

Guide the choice and dose of corticosteroid by the severity and chronicity of the condition, the patient’s medical history (particularly diabetes mellitus, as corticosteroids can cause significant transient elevations in blood glucose), prior response to injection, and the specific injection site. Caution is warranted regarding the frequency of repeat injections — current evidence suggests that no more than two to three corticosteroid injections per year at a given anatomical site should be performed, as repeated injections have been associated with tendon atrophy, weakening of the collagen matrix, and — in rare cases — tendon rupture.

Post-Injection Assessment: Confirming Therapeutic Placement

The post-injection assessment in this clinical case—specifically, systematic re-palpation of the greater trochanteric region to compare pain responses before and after injection—serves a critical diagnostic and prognostic function. As shown, our patient reported reduced tenderness at the gluteus medius tendon insertion after injection. In contrast, tenderness at the outer lateral aspect of the hip (over the greater trochanter itself) remained relatively preserved.

This differential response is highly informative. The reduction in tenderness over the gluteus medius tendon insertion confirms that the local anesthetic has been deposited in the correct anatomical compartment — at or adjacent to the tendon — and that the pain generator identified clinically corresponds to the structure targeted by the injection. This is sometimes referred to as a positive analgesic response to injection and provides important clinical confirmation of the diagnostic hypothesis.

Some tenderness in adjacent areas immediately after injection is expected. It does not indicate incorrect placement — it simply reflects that the local anesthetic has not fully infiltrated all of the sensitive structures in the region, which is entirely consistent with a targeted peritendinous injection technique.

Evidence-Based Rehabilitation for Gluteus Medius Tendinopathy: From Load Management to Progressive Tendon Loading

While the injection procedure described in this post provides valuable symptomatic relief and confirms the diagnosis, long-term management of gluteus medius tendinopathy depends on a structured, evidence-based rehabilitation program that addresses the underlying biomechanical and neuromuscular factors driving tendon pathology. The physiotherapy research of Alison Grimaldi, Rod Whiteley, Jill Cook, and colleagues has been particularly influential in establishing the current evidence-based framework for rehabilitation of GTPS and gluteus medius tendinopathy.

Stage 1: Education and Load Management

The first, and arguably most important, phase of rehabilitation focuses on patient education and modifying provocative loading patterns. This stage recognizes that many patients with gluteus medius tendinopathy inadvertently perpetuate and worsen their tendon pathology through habitual postures and movement patterns that create sustained or repetitive compressive loading at the tendon insertion.

Specific behavioral modifications that are central to this phase include:

Elimination of hip adduction postures. Patients are instructed to avoid sitting with legs crossed at the knee (which places the hip in adduction and internal rotation, compressing the gluteus medius tendon against the greater trochanter), standing with weight habitually shifted onto one hip, and sleeping on the affected side without a pillow between the knees. These modifications are typically immediate and significantly reduce symptom severity within the first 1 to 2 weeks of implementation.

Modification of sitting posture. Patients are encouraged to sit with hips at approximately 90 degrees (avoiding deep hip flexion beyond this angle, which amplifies compressive loading) and with feet flat on the floor, maintaining a neutral pelvic position. High chairs are preferable to low chairs, and sitting on hard surfaces is preferable to sitting on soft, compressive surfaces that allow further hip adduction.

Sleep positioning guidance. For patients who sleep on their side, a firm pillow between the knees maintains neutral hip abduction, preventing the hip from falling into adduction and compressing the tendon throughout the night. This simple intervention is often associated with dramatic improvement in nocturnal pain, one of the most disabling symptoms of GTPS.

Activity modification. Rather than complete rest — which is counterproductive for tendon health — patients are guided to identify and modify specific activities that provoke symptoms while maintaining other forms of physical activity that do not load the tendon in a compressive manner. Swimming, cycling (on a correctly fitted bicycle), and aquatic exercise are generally well-tolerated and can maintain cardiovascular fitness and muscle conditioning without provoking tendon symptoms.

Stage 2: Isometric Exercise for Pain Modulation

Once provocative loads have been reduced, and acute symptoms are beginning to settle, the second phase of rehabilitation introduces isometric hip abductor exercises — sustained muscular contractions without joint movement — as a strategy for both pain modulation and tendon loading.

The analgesic effects of isometric exercise for tendinopathy have been the subject of significant research interest following the seminal work of Rio and colleagues (2015), who demonstrated that isometric quadriceps contractions produced significant and immediate pain relief in patellar tendinopathy, an effect they attributed to cortical inhibition — the suppression of cortical pain processing pathways through the activation of descending inhibitory systems during sustained muscular contraction. While researchers have studied this analgesic effect most extensively in the patellar and Achilles tendons, they believe the neurophysiological mechanisms apply broadly across tendinopathies at multiple anatomical sites.

For gluteus medius tendinopathy, perform isometric hip abduction exercises in side-lying with the knee slightly flexed, holding the contraction for 45 seconds at 70% of maximum voluntary contraction for 4 to 5 repetitions, with about 2 minutes of rest between sets. These parameters have been shown to produce meaningful pain reduction both immediately after exercise and for up to 45 minutes following the session.

Stage 3: Isotonic and Eccentric Strengthening

As pain levels stabilize and the patient’s confidence in loading the hip increases, the rehabilitation program progresses to isotonic hip abductor strengthening exercises, initially performed in positions that avoid compressive loading of the tendon (i.e., without hip adduction) and gradually progressing toward positions that introduce controlled compressive loads as the tendon demonstrates tolerance.

Evidence for eccentric exercise in gluteus medius tendinopathy is somewhat less robust than for Achilles or patellar tendinopathy, where its efficacy is well established. However, heavy slow resistance (HSR) training — a protocol that involves slow, controlled repetitions of both the concentric and eccentric phases of hip abduction against significant resistance — has shown promising results in several clinical studies. A landmark randomized controlled trial by Beyer et al. (2015), conducted in Achilles tendinopathy, established that HSR training produces outcomes equivalent to eccentric training at 12 weeks and higher patient satisfaction; clinicians have since applied these principles with success to hip abductor rehabilitation protocols.

Key exercises in this phase include:

Side-lying hip abduction with resistance band. This foundational exercise targets the gluteus medius at an optimal length-tension relationship with minimal compressive loading. Progressive resistance is introduced by advancing from lighter to heavier resistance bands and eventually adding ankle weights.

Clamshell exercise. Performed in side-lying with hips and knees flexed to 60 degrees, the clamshell specifically targets the posterior fibers of the gluteus medius (the very fibers whose tendon insertion was the pain generator in our patient) in combination with external hip rotators. Progressive resistance with a resistance band above the knees.

Hip abductor machine strengthening. Once the patient tolerates loaded hip abduction in recumbent positions, seated or standing hip abduction machine exercises provide a higher-load stimulus for progressive tendon remodeling.

Wall slide with hip abduction. Performed in standing with the back against a wall, this exercise introduces controlled weight-bearing loads while maintaining a hip-neutral position that avoids compressive loading of the tendon insertion.

Stage 4: Functional and Sport-Specific Loading

The final phase of rehabilitation reintegrates the patient into full functional activities—including occupation, recreation, and sport—through a systematic, progressive loading program that mirrors the demands of their target activities. For a middle-aged patient like the one presented in this case, this phase might focus on tasks such as prolonged walking, stair negotiation, and occupational demands like prolonged standing or lifting, all of which stress the hip abductor system.

Key principles of this phase include progressive overload (gradually increasing load, volume, and exercise complexity), specificity (exercises that replicate the movement demands of the target activity), and a graduated reintroduction of previously provocative activities such as single-leg stance, step-up exercises, and, if applicable, running.

Gait retraining is an important component of functional rehabilitation for patients who demonstrate abnormal lower limb kinematic patterns during walking or running. Targeted interventions may include instruction in maintaining trunk stability during single-leg support, reducing lateral trunk tilt, and optimizing step width to reduce compressive loads on the gluteus medius tendon during gait.

Extracorporeal Shockwave Therapy for Greater Trochanteric Pain Syndrome

Extracorporeal shockwave therapy (ESWT) has emerged as one of the most evidence-supported non-surgical treatments for chronic gluteus medius tendinopathy and GTPS that have failed to respond to conservative management. ESWT delivers high-energy acoustic pressure waves to the target tissue using a focused or radial shockwave device, producing a cascade of mechanical and biological effects that promote tendon healing and reduce pain.

Mechanisms of Action

The biological mechanisms by which ESWT exerts its therapeutic effects are multiple and interdependent. Mechanotransduction — the conversion of mechanical stimuli into cellular biochemical signals — activates tenocytes and stimulates the production of growth factors including transforming growth factor-beta 1 (TGF-?1), basic fibroblast growth factor (bFGF), and insulin-like growth factor-1 (IGF-1), all of which promote collagen synthesis and matrix remodeling. ESWT also appears to disrupt neovascular ingrowth and associated nerve fibers that contribute to chronic tendinopathy pain, potentially by affecting substance P signaling and nociceptor sensitization.

Additionally, ESWT has been shown to promote the fragmentation and resorption of calcific deposits within tendons — a common finding in chronic GTPS — through cavitation effects that mechanically disrupt calcium hydroxyapatite crystals, facilitating their phagocytic removal by macrophages.

Clinical Evidence for ESWT in GTPS

The strongest clinical evidence for ESWT in GTPS comes from a series of randomized controlled trials by Rompe and colleagues. In their 2009 study comparing ESWT, corticosteroid injection, and eccentric exercise in 229 patients with GTPS, they demonstrated that at 15 months follow-up, ESWT produced significantly superior outcomes compared to corticosteroid injection, with a 61% success rate for ESWT versus 51% for eccentric exercise and 48% for corticosteroid injection at 15 months. Subsequent trials have replicated and extended these findings, establishing ESWT as a first-line treatment for patients with chronic GTPS who have not responded to simple conservative measures.

ESWT is typically delivered in 3 to 5 weekly sessions, using either focused shockwave (which delivers energy to a precise focal point deep within the tissue) or radial shockwave (which disperses energy more broadly across a larger tissue volume) modalities. Clinicians titrate energy level and pulses per session based on patient tolerance and treatment response, with typical parameters of 1,500 to 3,000 pulses per session at energy flux densities of 0.08 to 0.28 mJ/mm² for radial ESWT, or lower flux densities for focused devices.

Platelet-Rich Plasma Injections: Emerging Evidence for Tendon Regeneration

Platelet-rich plasma (PRP) is an autologous blood product derived by centrifuging a small volume of the patient’s peripheral blood to concentrate platelets (and their associated growth factors) to several times the baseline platelet concentration in whole blood. When injected into the site of tendon pathology, PRP delivers a concentrated payload of growth factors — including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), TGF-?1, epidermal growth factor (EGF), and IGF-1 — directly to the degenerative tendon tissue, theoretically stimulating matrix synthesis and regeneration.

Rationale and Biological Mechanism

The rationale for PRP in tendinopathy stems from the recognition that degenerative tendons have fundamentally impaired intrinsic healing capacity — partly due to their relative avascularity (tendons have limited direct blood supply) and partly due to the phenotypic changes in tenocyte populations that reduce their responsiveness to normal repair signals. By delivering a supraphysiological concentration of growth factors directly to the tendon, PRP attempts to overcome this healing deficit and shift the tendon matrix toward active repair and remodeling.

Leukocyte-rich PRP (L-PRP) versus leukocyte-poor PRP (LP-PRP) preparations represent an important distinction in PRP formulation. L-PRP contains a high concentration of white blood cells, along with platelets and their growth factors, and theoretically provides enhanced antimicrobial and catabolic activity alongside anabolic signals. However, the high concentration of pro-inflammatory cytokines in L-PRP preparations — particularly IL-1?, IL-6, and TNF-? from neutrophils — may paradoxically impair tendon healing and worsen tendon degeneration in some contexts. LP-PRP, which removes most leukocytes through additional centrifugation steps, provides a more purely anabolic signal and may be better suited to tendinopathy applications. However, clinical evidence comparing these formulations specifically in gluteus medius tendinopathy remains limited.

Clinical Evidence in Gluteus Medius Tendinopathy and GTPS

The evidence base for PRP in GTPS specifically is more limited than for conditions such as lateral epicondylitis (tennis elbow) or chronic Achilles tendinopathy, where several high-quality randomized controlled trials have been conducted. However, the available evidence from smaller clinical studies and case series is encouraging. A prospective study by Fitzpatrick et al. (2018) showed significant improvements in pain and function scores at 3 and 6 months after an ultrasound-guided LP-PRP injection into the gluteus medius tendon in patients with chronic GTPS who had failed corticosteroid injection therapy. Importantly, no significant adverse effects were reported.

Given the current evidence landscape, PRP represents a reasonable second-line option for patients with chronic, refractory gluteus medius tendinopathy who have not achieved sustained benefit from corticosteroid injection and comprehensive rehabilitation. Ideally, perform the procedure under ultrasound guidance to ensure precise intratendinous or peritendinous delivery, and combine it with a structured, progressive loading rehabilitation program in the weeks following injection to maximize the anabolic stimulus from the delivered growth factors.

The Role of Corticosteroids: Benefits, Risks, and Best Practices

Given the extensive use of corticosteroid injections in clinical practice for gluteus medius tendinopathy, a detailed examination of their benefits, risks, and optimal use is warranted.

Short-Term Benefits

The short-term analgesic and anti-inflammatory benefits of corticosteroid injections are well-documented. For patients experiencing significant pain that is limiting their ability to engage with rehabilitation — a common clinical scenario in moderate-to-severe GTPS — a corticosteroid injection can provide rapid, meaningful pain relief within 48 to 72 hours that enables the initiation of the therapeutic exercise program that drives long-term recovery. In this context, the injection serves as a facilitator of rehabilitation rather than a standalone treatment.

Additionally, for patients in whom pain is severely disrupting sleep — a particularly debilitating feature of GTPS that compounds fatigue, reduces daytime functional capacity, and may impair the neuroplastic processes required for motor learning and rehabilitation — a corticosteroid injection can produce rapid improvement in nocturnal symptoms, breaking the cycle of pain-related sleep disruption that perpetuates both the symptom burden and the patient’s capacity to participate in recovery activities.

Risks and Adverse Effects

The risks associated with peritendinous corticosteroid injection are well-characterized and include:

Post-injection flare. A transient increase in pain at the injection site, typically occurring within 6 to 24 hours of injection and lasting 24 to 72 hours, is reported by approximately 10 to 20% of patients. This is believed to reflect a local inflammatory response to the corticosteroid crystal microparticles before absorption, and it can be managed with ice and analgesics. Counsel patients about this possibility before the procedure.

Skin depigmentation and subcutaneous fat atrophy. Superficial deposition of corticosteroid into the dermis or subcutaneous fat can cause localized hypopigmentation and fat atrophy—a cosmetically undesirable outcome that is more common in patients with darker skin tones. This risk is minimized by ensuring the injection is directed to the correct depth (at or adjacent to the tendon insertion) rather than deposited superficially.

Tendon weakening and risk of rupture. As discussed, intratendinous corticosteroid injection has been associated with impaired tenocyte function, reduced collagen synthesis, and structural tendon weakening. While peritendinous injection carries a lower risk than direct intratendinous injection, caution is still warranted. Advise patients to avoid high-impact activities for 4 to 6 weeks after injection to reduce the risk of tendon injury during the period of potential temporary weakening.

Diabetic hyperglycemia. Corticosteroid injection can clinically significantly elevate blood glucose in patients with diabetes mellitus, typically starting within 24 hours of injection and potentially lasting up to 7 days, depending on the agent and dose used. Counsel diabetic patients about this risk and have them monitor blood glucose more frequently in the days following injection.

Infection. Post-injection septic arthritis or septic bursitis is rare (estimated incidence approximately 1 in 10,000 to 1 in 50,000 injections) but serious. Strict adherence to aseptic technique — as demonstrated in this clinical case — is the primary defense against this complication.

Understanding Greater Trochanteric Pain Syndrome Beyond the Tendon: Differential Diagnosis and Comorbid Conditions

While gluteus medius tendinopathy is the predominant cause of lateral hip pain in most patients presenting with GTPS, clinicians should maintain a broad differential diagnosis and consider comorbid conditions that may contribute to or confound the clinical presentation.

Lumbar Radiculopathy and Referred Pain

Lumbar radiculopathy involving the L4, L5, or S1 nerve roots can produce referred pain patterns that closely mimic lateral hip pain. The superior gluteal nerve (L4–S1), which innervates the gluteus medius and gluteus minimus, can be compressed or irritated at the level of the lumbar spine or within the pelvis, producing both pain referral to the lateral hip region and neurogenic inhibition of the gluteus medius muscle. A careful lumbar spine examination — including neurological assessment, straight leg raise testing, and assessment of lumbar range of motion — is an essential component of the workup for any patient presenting with lateral hip pain.

In patients with concomitant lumbar spine pathology and GTPS, the clinical management must address both components simultaneously. Addressing the spinal component through manual therapy, targeted exercise, or — in severe cases — interventional spine procedures may restore normal gluteus medius activation and reduce the mechanical vulnerability of the tendon. In contrast, concurrent tendon rehabilitation addresses the local pathology.

Hip Joint Pathology: Labral Tears and Femoroacetabular Impingement

Intra-articular hip pathology, including acetabular labral tears and femoroacetabular impingement (FAI), can produce pain that radiates laterally and is perceived in the trochanteric region. These conditions typically cause additional symptoms, including groin pain, clicking or catching sensations in the hip joint, pain with deep hip flexion and rotation, and restricted hip range of motion—features that help distinguish them from isolated GTPS. However, intra-articular pathology can coexist with gluteus medius tendinopathy, and comprehensive evaluation must consider both possibilities.

Iliotibial Band Syndrome and Tensor Fasciae Latae Pathology

The iliotibial band (ITB) is a thick fascial structure that runs along the lateral thigh from the iliac crest to the lateral tibial condyle (Gerdy’s tubercle), passing directly over the lateral aspect of the greater trochanter. ITB syndrome — caused by repetitive friction of the band over the lateral femoral epicondyle — is a distinct condition that primarily produces lateral knee pain. Still, proximal ITB tightness can increase compressive loading of the greater trochanter and may coexist with or worsen gluteus medius tendinopathy. Assessing ITB flexibility with the Ober test is a useful part of the physical examination in patients with lateral hip pain.

Piriformis Syndrome and Deep Gluteal Space Pathology

Piriformis syndrome — a controversial but clinically recognized condition in which the sciatic nerve is compressed or irritated by the piriformis muscle within the deep gluteal space — produces buttock pain that may radiate into the posterior hip region and can occasionally be perceived laterally. Distinguishing piriformis syndrome from gluteus medius tendinopathy requires careful palpatory assessment (piriformis tenderness is typically located more medially and posteriorly, in the region of the greater sciatic notch), assessment of hip rotation (piriformis syndrome typically produces pain with passive internal rotation of the hip), and consideration of the neural (radiating, burning, or tingling) versus purely musculoskeletal quality of the pain.

Stress Fractures of the Femoral Neck

Stress fractures of the femoral neck must always be considered in the differential diagnosis of hip pain, particularly in older patients, postmenopausal women (who are at increased risk due to osteoporosis), and patients whose pain is provoked by impact activities or weight-bearing. Femoral neck stress fractures may present with lateral hip pain that mimics GTPS, but typically demonstrate pain with axial loading (single-leg hop test), night pain at rest, and disproportionate functional limitation relative to the clinical findings. Any suspicion of femoral neck stress fracture warrants immediate imaging (MRI is the most sensitive modality) and cessation of weight-bearing activities until the diagnosis is excluded, as a missed stress fracture can progress to complete femoral neck fracture with catastrophic consequences.

Neuroanatomy and Pain Science: Understanding the Patient’s Pain Experience

A comprehensive approach to managing gluteus medius tendinopathy cannot be limited to the condition’s mechanical and structural aspects. Modern pain science has fundamentally transformed our understanding of why some patients with relatively minor structural tendon changes experience severe, disabling pain. In contrast, others with extensive tendon degeneration on imaging are largely asymptomatic. This understanding has profound implications for how we communicate with patients, design treatment programs, and set realistic recovery expectations.

Central Sensitization in Chronic Tendinopathy

Central sensitization refers to the amplification of nociceptive signaling within the central nervous system (CNS) — specifically within the spinal cord dorsal horn and supraspinal pain-processing regions — that occurs as a consequence of prolonged or intense peripheral pain input. In central sensitization, the threshold for pain is lowered, the magnitude of pain in response to a given stimulus is amplified, and the spatial area of pain hypersensitivity is expanded beyond the original site of injury (a phenomenon called secondary hyperalgesia).

In the context of gluteus medius tendinopathy, central sensitization can explain why some patients experience pain during activities that should place only modest loads on the tendon, why the pain area may expand beyond the discrete tendon insertion to encompass a broader region of the lateral hip and thigh, and why pain may persist. Disability may continue even after local peripheral pathology improves. Recognizing central sensitization features in a patient’s presentation matters because it indicates the need for pain neuroscience education and centrally directed pain management strategies—including graded exposure, cognitive-behavioral approaches, and, in some cases, pharmacological neuromodulation—alongside traditional musculoskeletal rehabilitation.

Patient Education and the Therapeutic Alliance

Research in pain science has consistently shown that patient understanding of their condition—specifically, accurate knowledge of the non-threatening nature of tendinopathy pain, the mechanisms of sensitization, and the role of movement and loading in recovery—is itself a therapeutic intervention. When delivered effectively, pain neuroscience education (PNE) has been shown to reduce pain catastrophizing, increase active coping, and improve functional outcomes in musculoskeletal conditions, including tendinopathy.

In the clinical interaction demonstrated in this post, the clinician’s careful explanation of the injection procedure, confirmation of correct needle placement, and communication of the diagnostic significance of the post-injection analgesic response all contribute to the patient’s understanding of their condition and provide a basis for optimism about recovery. This therapeutic alliance—the partnership between clinician and patient built on clear communication, shared understanding, and mutual trust—is a foundational element of effective clinical care that is often underappreciated in procedural interventions.

Surgical Management of Gluteus Medius Tendinopathy: Indications and Outcomes

For the large majority of patients with gluteus medius tendinopathy, conservative management — including behavioral modification, rehabilitation exercise, corticosteroid or PRP injection, and ESWT — will produce satisfactory outcomes. However, a subset of patients with refractory, chronic tendinopathy — particularly those with large partial-thickness or full-thickness gluteus medius tendon tears — may ultimately require surgical intervention.

Surgical Approaches

Endoscopic repair of gluteus medius tendon tears has emerged as the preferred surgical approach for refractory cases, offering the lesser incisions, reduced soft-tissue trauma, and earlier rehabilitation compared with surgery. The technique involves arthroscopic visualization of the greater trochanteric region and systematic debridement of degenerative tendon tissue, followed by reattachment of the torn tendon fibers to the greater trochanteric bone using suture anchors.

Bursectomy — surgical excision of the inflamed trochanteric bursa — may be performed concurrently with tendon repair in cases where significant bursal pathology coexists with tendon tears. However, isolated bursectomy without addressing the tendon pathology has generally produced less satisfactory long-term outcomes.

Outcomes Data

The clinical outcomes literature for surgical repair of gluteus medius tendon tears is growing but remains less robust than for other hip conditions such as FAI surgery. Available case series and retrospective studies report good to excellent patient-reported outcomes in approximately 70 to 85% of cases at medium-term follow-up, with significant improvements in pain, hip abductor strength, and functional measures. Recovery following surgical repair typically requires 3 to 6 months of structured rehabilitation, beginning with protected weight-bearing and progressive tendon loading in the initial weeks and advancing to full functional activities over 4 to 6 months.

Patient selection is critical to optimizing surgical outcomes. The best candidates for surgical repair are patients with large, well-defined tendon tears (particularly full-thickness tears involving the superoposterior facet), significant functional disability despite comprehensive non-operative management, and preserved or minimally impaired muscle quality on MRI (the presence of significant muscle atrophy with fatty infiltration substantially reduces the likelihood of a successful repair and functional recovery).

Special Considerations in Managing Lateral Hip Pain in Older Adults

The patient in this case—a 57-year-old male—represents a population with several clinical considerations that influence both the diagnostic approach and management strategy for gluteus medius tendinopathy.

Bone Health and Osteoporosis

In patients over 50, assessment of bone mineral density is relevant, particularly when considering the feasibility and appropriateness of corticosteroid injection therapy. Systemic corticosteroid use is a well-recognized cause of secondary osteoporosis, but the risk from infrequent local corticosteroid injections is generally considered minimal for most patients. Nevertheless, clinicians should be aware of pre-existing osteopenia or osteoporosis as a background factor that may influence the biomechanical vulnerability of the proximal femur and the recovery trajectory following interventions.

Cardiovascular and Metabolic Comorbidities

Patients in the fifth and sixth decades of life frequently present with cardiovascular risk factors and metabolic comorbidities — including hypertension, dyslipidemia, type 2 diabetes, and obesity — that can significantly influence both the pathophysiology of their musculoskeletal condition and the safety of treatment interventions. As previously discussed, type 2 diabetes is associated with impaired tendon healing and more severe tendinopathy, while obesity increases mechanical loads on the hip abductor tendons. A holistic approach to managing these patients addresses not only the local tendon pathology but also the systemic metabolic context in which it developed.

Physical Activity and Deconditioning

Many patients in this age group have experienced a gradual decline in physical activity levels, often attributed to a combination of work demands, family commitments, and the onset of musculoskeletal pain — including the lateral hip pain that brings them to clinical attention. This deconditioning compounds the neuromuscular deficits associated with gluteus medius tendinopathy by reducing overall muscle strength, endurance, and motor control. Rehabilitation programs for these patients must therefore address not only specific hip abductor strengthening but also the broader context of aerobic fitness, lower-limb strength, and proprioceptive function that support optimal hip mechanics.

Pharmacological Considerations in Older Adults

The prescription of analgesic and anti-inflammatory medications in older patients requires careful consideration of the increased risks of adverse effects in this population. Non-steroidal anti-inflammatory drugs (NSAIDs), while commonly used for musculoskeletal pain management, carry significantly elevated risks in older adults, including gastrointestinal ulceration and hemorrhage, cardiovascular events, and renal impairment — particularly with prolonged use or in patients with pre-existing cardiovascular or renal disease. Topical NSAID preparations (such as diclofenac gel) offer a safer alternative for localized pain management, delivering therapeutic drug concentrations to the target tissue with substantially reduced systemic absorption and adverse effect risk.

Paracetamol (acetaminophen) remains a safe first-line analgesic for many older adults, though its role in managing tendinopathy pain is limited given the non-inflammatory nature of the primary pathology.

The Biomechanics of Gait and Their Relevance to Gluteus Medius Tendinopathy

Understanding the biomechanics of normal and abnormal gait is central to a comprehensive approach to managing gluteus medius tendinopathy, both for understanding why the condition develops and for designing targeted interventions that address the root mechanical causes.

Normal Hip Abductor Function During Gait

During normal walking, the single-limb support phase — the portion of the gait cycle in which all body weight is supported on one leg while the other is in swing — creates a large abductor moment demand at the hip. The body’s center of mass lies medial to the hip joint, creating a gravitational torque that tends to drop the contralateral pelvis. The gluteus medius (and, to a lesser extent, the gluteus minimus and tensor fasciae latae) must generate a sufficient abductor force to counteract this gravitational torque and maintain a level or near-level pelvis throughout single-limb support.

Biomechanical analyses using three-dimensional motion capture have demonstrated that the hip abductor force during walking can reach 2.5 to 3 times body weight in normal subjects. For a patient with significant body weight, this translates to very large compressive and tensile forces at the gluteus medius tendon insertion, forces that, when applied repeatedly over thousands of steps per day, cumulatively challenge the tendon’s adaptive capacity.

Abnormal Gait Patterns and Tendon Overload

Several abnormal gait patterns are associated with increased loading of the gluteus medius tendon and elevated risk of tendinopathy:

Contralateral pelvic drop (Trendelenburg gait): When the gluteus medius fails to generate sufficient abductor force during single-limb support, the contralateral pelvis drops below the level of the supported side — a pattern known as the Trendelenburg gait. This pelvic drop increases the adduction angle at the ipsilateral hip, placing the gluteus medius tendon under increased compressive loading at its trochanteric insertion. It also increases the valgus moment at the knee, contributing to patellofemoral and medial knee stress — illustrating how proximal hip dysfunction can produce distal lower extremity pathology.

Ipsilateral trunk lean: Some patients compensate for gluteus medius weakness by leaning their trunk toward the supported side during single-limb stance, thereby shifting the center of mass laterally and reducing the abductor moment demand at the hip. While this strategy effectively reduces demand on the gluteus medius, it increases lumbar spine loading and may contribute to back pain as a secondary complaint.

Narrow step width: In some patients — particularly runners — a narrow or crossover step width (in which the foot is planted medial to the line of progression) forces the hip into relative adduction with each footfall, creating a sustained adduction moment that amplifies compressive loading of the gluteus medius tendon throughout the stance phase.

Gait Retraining as a Therapeutic Intervention

Gait retraining — the systematic modification of dysfunctional movement patterns through real-time visual or auditory feedback — has been shown to produce clinically meaningful reductions in hip joint loads and symptom reduction in patients with lateral hip pain. Studies by Noehren and colleagues demonstrated that real-time feedback targeting contralateral pelvic drop during running produced significant, durable reductions in hip adduction kinematics and associated tissue loads, with improvements persisting at 1-month follow-up after the retraining period ended.

For patients with gluteus medius tendinopathy, a gait analysis — ideally using instrumented three-dimensional motion capture but feasibly performed using two-dimensional video analysis in clinical settings — provides valuable information to guide targeted biomechanical interventions, including step width modification, trunk position feedback, and progressive single-leg balance training to improve neuromuscular control of the pelvis during walking and running.

Corticosteroid Injection Versus Shockwave Therapy Versus PRP: A Comparative Evidence Summary

The management of gluteus medius tendinopathy and GTPS has been the subject of an increasing number of high-quality clinical trials over the past two decades, providing a growing evidence base to guide treatment decision-making. The following summary synthesizes the key comparative evidence.

Corticosteroid Injection: The Short-Term Leader

Corticosteroid injection consistently demonstrates superior short-term pain reduction (at 4 to 8 weeks) compared to most other non-surgical interventions, including ESWT and exercise therapy. This makes it a valuable first-line option for patients with significant pain that is limiting function and rehabilitation engagement. However, the advantages of corticosteroid injection are not maintained at medium-term follow-up (12 to 15 months), where exercise and ESWT typically demonstrate equivalent or superior outcomes.

Extracorporeal Shockwave Therapy: The Long-Term Performer

ESWT demonstrates superior medium- and long-term outcomes compared to corticosteroid injection and produces results equivalent to structured exercise therapy in most trials. Its non-invasive nature, favorable safety profile, and durable effects make it particularly attractive for patients who are averse to injection or have had insufficient long-term benefit from corticosteroid therapy.

Platelet-Rich Plasma: A Promising Alternative

PRP injection, while supported by less robust evidence than corticosteroid or ESWT in GTPS specifically, represents a rational and promising treatment option, particularly for patients with refractory tendinopathy or in whom corticosteroid injection is relatively contraindicated (e.g., patients with diabetes who are poorly controlled, or patients with prior adverse effects from corticosteroid injection). The regenerative potential of PRP, grounded in its growth factor payload, theoretically addresses the underlying pathological mechanism of tendon degeneration in a way that corticosteroids do not.

The Hierarchy of Evidence-Based Treatment

Based on the current evidence, a rational, hierarchical approach to the treatment of gluteus medius tendinopathy might proceed as follows:

1. First-line: Patient education, load management, and structured progressive exercise (Stages 1–3 as described above), with or without concurrent ESWT
2. Adjunct to rehabilitation: Corticosteroid injection for patients with moderate-to-severe pain limiting rehabilitation engagement, combined with structured exercise
3. Second-line (refractory cases): PRP injection, typically performed after 3 to 6 months of failed conservative management
4. Third-line (severe, refractory cases with structural pathology): Surgical consultation for patients with large tendon tears and significant functional disability

Integrating Manual Therapy and Chiropractic Care in the Management of Lateral Hip Pain

As a clinician who practices at the intersection of chiropractic medicine and advanced practice nursing, I take an integrative approach to patients with gluteus medius tendinopathy, drawing on the complementary strengths of both disciplines. Integrating manual therapy—including spinal manipulation, soft tissue techniques, and joint mobilization—with evidence-based rehabilitation and, where appropriate, interventional procedures offers a comprehensive framework for addressing the multiple factors contributing to lateral hip pain.

Lumbar and Pelvic Manipulation

Spinal manipulative therapy targeting the lumbopelvic region can address biomechanical dysfunction within the lumbar spine and sacroiliac joints that contributes to abnormal hip mechanics and gluteus medius loading. Research has demonstrated that sacroiliac joint dysfunction — characterized by altered load transfer through the pelvic ring — is associated with impaired gluteus medius activation and reduced hip abductor force production, likely through a mechanism of arthrogenic muscle inhibition. Manipulating hypomobile sacroiliac or lumbar spinal segments can reduce this inhibition, allowing improved volitional gluteus medius activation during rehabilitation exercises.

Hip Joint Mobilization and Distraction

Hip joint mobilization — the application of graded passive movements to the hip joint — can address the capsular restrictions and joint surface congruency issues that contribute to abnormal femoral head movement within the acetabulum during loaded activities. Posterolateral hip capsule tightness, in particular, has been associated with increased anterior femoral glide during hip flexion, which in turn amplifies the compressive loads experienced by the anterior and lateral trochanteric tendons.

Distraction manipulation of the hip joint, performed with the patient in supine and the clinician applying long-axis traction through the femur, can improve hip joint space, reduce capsular tension, and provide immediate improvements in hip range of motion and symptom reduction, creating a favorable environment for rehabilitation exercise.

Soft Tissue Techniques: Active Release Therapy and Instrument-Assisted Soft Tissue Mobilization

Active Release Therapy (ART) and instrument-assisted soft tissue mobilization (IASTM) techniques target the peritendinous connective tissue and the interface between the gluteus medius tendon and adjacent structures, aiming to break down adhesions, restore normal tissue gliding, and stimulate mechanoreceptive responses that modulate pain. While evidence for these techniques in gluteus medius tendinopathy specifically is limited, clinicians use them widely, and they align with the broader evidence for soft tissue techniques in tendinopathy management.

Nutritional and Lifestyle Factors in Tendon Health and Recovery

An increasingly recognized but frequently underaddressed dimension of tendinopathy management involves the role of nutrition and lifestyle factors in tendon health, healing, and recovery. Emerging research shows that specific nutritional substrates are critical for optimal collagen synthesis and tendon repair, and that lifestyle factors, including sleep, stress, and physical activity patterns, profoundly influence the inflammatory and regenerative milieu in which tendon healing occurs.

Collagen Precursors: Glycine, Proline, Vitamin C, and Gelatin

Collagen is the predominant structural protein of tendons. Its synthesis requires specific amino acid precursors—particularly glycine and proline—as well as the cofactor vitamin C (ascorbic acid), which hydroxylates proline residues and cross-links collagen chains, giving the protein strength. Studies have shown that consuming GCF before collagen peptides significantly increased circulating amino acid concentrations and enhanced collagen synthesis in tendon and ligament tissue compared to a placebo control. This finding has led to the practical recommendation that patients undergoing tendon rehabilitation consume a collagen-enriched food or supplement (such as gelatin-based foods, collagen peptide supplements, or foods high in vitamin C and collagen precursors) approximately 1 hour before their exercise sessions, to maximize the anabolic stimulus on the tendon during the loading period.

Dietary protein more broadly plays an essential role in supporting musculoskeletal health and recovery. For older patients with gluteus medius tendinopathy, adequate total protein intake—typically recommended at 1.2 to 1.6 grams per kilogram of body weight per day for active adults over 50—supports both muscle and tendon repair and helps counteract the anabolic resistance that characterizes older muscle tissue.

Sleep and Recovery

Sleep is perhaps the most important, yet least clinically addressed, recovery modality for tendinopathy. During sleep, anabolic hormone secretion — including growth hormone and testosterone — peaks, providing the hormonal environment most conducive to tissue repair and collagen synthesis. Chronic sleep deprivation suppresses these anabolic signals and elevates cortisol and pro-inflammatory cytokines, creating a systemic catabolic milieu that impairs tendon healing and may perpetuate the degenerative cycle.

For patients with gluteus medius tendinopathy, improving sleep quality is therefore not merely a quality-of-life issue but a directly therapeutic intervention. Strategies to improve sleep in this population include the positional modifications described earlier (pillow between knees to prevent hip adduction and nocturnal pain), sleep hygiene education, and — where appropriate — pharmacological or non-pharmacological interventions for concomitant sleep disorders such as insomnia.

Psychological Factors and Stress

The relationship between psychological stress and tendinopathy severity is supported by a growing body of research demonstrating that elevated cortisol levels — a direct consequence of psychological stress — suppress collagen synthesis, impair tenocyte function, and amplify central pain sensitization. Patients with high levels of work stress, anxiety, or depression demonstrate poorer outcomes from tendinopathy rehabilitation than psychologically healthier individuals, even when controlling for the severity of structural tendon pathology.

Addressing psychological well-being through counseling, stress management strategies, and social support is therefore a legitimate component of comprehensive tendinopathy management, one that evidence-based guidelines increasingly recognize but that requires sensitive, thoughtful integration into the clinical consultation.

Advanced Diagnostic Techniques: Elastography and Quantitative MRI in Tendon Assessment

The frontier of musculoskeletal imaging in tendinopathy has expanded significantly ,with quantitative imaging techniques that go beyond the morphological assessment provided by conventional ultrasound and MRI to directly measure tendon mechanical properties and tissue composition 

Sonoelastography

Ultrasound elastography—also called sonoelastography—is an advanced ultrasound technique that measures soft-tissue stiffness by assessing deformation in response to an applied mechanical force (strain elastography) or a shear wave induced by focused ultrasound pulses (shear wave elastography). Normal tendon tissue is stiff and deforms minimally under applied force, appearing in distinctive colors on elastography maps that reflect relative tissue stiffness. In tendinopathy, areas of matrix disorganization and increased water content are significantly less stiff than normal tendon and appear as softened (color-coded as softer) regions on the elastography map.

Several studies have applied shear wave elastography (SWE) to the gluteus medius tendon, demonstrating a consistent reduction in tendon stiffness in symptomatic tendons compared with asymptomatic controls. This quantitative stiffness measurement may serve as a biomarker of tendon pathology severity and an objective measure of treatment response—providing data beyond pain scales and patient-reported outcome measures to assess the biological state of tendon tissue directly.

Quantitative MRI Techniques

T2 mapping and ultrashort echo time (UTE) MRI are advanced MRI sequences that provide quantitative information about collagen organization and water content within tendons with a level of detail that is not accessible through conventional MRI. T2 relaxation time is prolonged in areas of collagen disorganization and increased free water content — changes that correspond to the histopathological features of tendinopathy. UTE sequences, which capture signal from the very short T2* tissues (such as densely organized collagen), can detect early disruption of collagen architecture before gross morphological changes are visible on conventional MRI.

These quantitative imaging tools are currently predominantly research modalities, but their transition into clinical practice is anticipated as the technology becomes more accessible and the interpretive normative data mature. Their future clinical utility lies in early detection of tendon pathology before symptom onset, monitoring treatment response with greater objectivity than currently available measures, and guiding return-to-activity decisions with a biomechanical evidence base.

Managing Refractory Cases: A Multi-Modal Clinical Protocol

In clinical practice, some patients with gluteus medius tendinopathy will not achieve satisfactory outcomes with any single treatment modality. These refractory cases require a carefully considered multi-modal approach that systematically addresses each potential contributor to treatment failure.

Common reasons for treatment failure in gluteus medius tendinopathy include:

Inadequate load management: Patients who continue to expose the tendon to compressive or excessive tensile loads despite education and advice will not heal, regardless of other treatments. Reassess postural habits, work environment ergonomics, and daily activity patterns in any refractory case.

Incorrect diagnosis: The presence of a confounding or alternative diagnosis — such as lumbar radiculopathy, hip joint pathology, or referred visceral pain — can render tendon-directed treatments ineffective. Comprehensive reassessment with updated imaging and a fresh diagnostic perspective is warranted.

Inadequate rehabilitation adherence or exercise intensity: The evidence clearly shows that tendon loading programs require sufficient mechanical stimulus to drive remodeling — exercises that are too light, too infrequent, or performed with poor technique will not produce the necessary adaptation. A supervised rehabilitation program with objective monitoring of exercise intensity is more effective than unsupervised home exercise programs.

Concurrent central sensitization: As discussed, patients with significant central sensitization require adjunctive pain science education and centrally-directed pain management strategies that address the neurological amplification of their pain experience, rather than purely peripheral interventions.

Metabolic or systemic factors: Poorly controlled diabetes, significant obesity, dyslipidemia, or other metabolic conditions that impair tendon healing require specific management alongside local tendon rehabilitation.

For refractory patients, my clinical practice at HealthVoice360 employs a structured multi-modal protocol that may include:

1. Comprehensive reassessment with advanced imaging (MRI with T2 mapping or shear wave elastography)
2. Ultrasound-guided PRP injection with precise peritendinous or intratendinous delivery
3. A structured ESWT course (5 sessions over 5 weeks)
4. High-load, supervised isotonic and eccentric strengthening with weekly progression monitoring.
5. Pain neuroscience education and, where indicated, psychological support
6. Metabolic optimization in collaboration with the patient’s primary care provider or endocrinologist
7. Gait analysis and targeted biomechanical retraining

This multi-modal framework addresses the full complexity of refractory tendinopathy and has produced clinically meaningful outcomes in patients who have previously failed more limited treatment approaches.

Clinical Observations from HealthVoice360: Integrating the Latest Evidence

Through my ongoing clinical practice at HealthVoice360.com, I have evaluated and treated hundreds of patients with gluteus medius tendinopathy and greater trochanteric pain syndrome across a wide spectrum of ages, activity levels, and clinical presentations. Several key clinical insights from this experience complement and extend the evidence base summarized in this post.

The Importance of Precise Diagnosis

In my clinical experience, the single most common reason for suboptimal treatment outcomes in patients with lateral hip pain is diagnostic imprecision — specifically, the failure to differentiate between the various structural contributors to GTPS (gluteus medius tendinopathy, gluteus minimus tendinopathy, trochanteric bursitis, ITB involvement) and the failure to identify and address concomitant lumbar or hip joint pathology. The comprehensive, structured physical examination approach described in this post—supplemented by point-of-care musculoskeletal ultrasound when available—provides diagnostic precision that substantially improves treatment targeting and outcomes.

The Critical Role of Patient Education

Across all treatment modalities, the patients who achieve the best outcomes are those who have the clearest understanding of their condition — specifically, who understand that their tendon pain is the result of a degenerative process driven by mechanical overload, that recovery requires both reduction of harmful loads and gradual reintroduction of therapeutic loads, and that the timeline for meaningful improvement is measured in months rather than days or weeks. Investing time in patient education at the start of the treatment episode significantly improves adherence to the rehabilitation program and sets realistic expectations.

Combining Injection with Immediate Rehabilitation

In my practice, corticosteroid or PRP injection is always combined with the immediate initiation of a structured rehabilitation program. I do not recommend complete rest after injection; instead, I use the pain relief to introduce the isometric and early isotonic exercises described in Stage 2 of the rehabilitation protocol while the patient’s pain levels are most amenable to loading. This concurrent approach — injection plus immediate exercise — has been shown in several trials to produce superior outcomes compared to injection alone.

The Value of Reassessment

Regular reassessment of treatment response — using both patient-reported outcome measures (such as the VISA-G questionnaire for gluteal tendinopathy) and objective clinical measures (hip abductor strength testing, single-leg stance test, palpatory response) — is essential for monitoring progress, identifying treatment failure early, and making timely adjustments to the management plan. In my practice, I reassess formally every 4 weeks throughout the rehabilitation program, using objective progress data to guide treatment modifications rather than symptom severity alone.

Summary

In this comprehensive educational post, we have explored the full clinical landscape of gluteus medius tendinopathy and greater trochanteric pain syndrome (GTPS) — from the foundational anatomy of the greater trochanter and gluteus medius tendon through to the frontiers of quantitative imaging and regenerative injection therapy. The clinical case of our 57-year-old male patient, presenting with a two-month history of posterior and superior trochanteric pain, provided the practical anchor for a wide-ranging exploration of the evidence base surrounding this common and clinically significant condition.

We have established that GTPS is not simply “trochanteric bursitis” — a historical misnomer that led to decades of suboptimally targeted treatment — but rather a syndrome predominantly driven by gluteus medius tendinopathy, a degenerative process within the tendon itself that follows the well-characterized pathophysiological continuum from reactive tendinopathy through dysrepair to frank degeneration. Researchers have comprehensively examined the role of compressive loading at the insertional tendon site, driven by hip adduction postures, biomechanical gait abnormalities, and intrinsic risk factors including age, sex, body mass, and metabolic health.

The clinical assessment approach—anchored by palpatory provocation testing, orthopedic special tests, and imaging with musculoskeletal ultrasound or MRI—provides the diagnostic foundation for targeted treatment. The injection procedure demonstrated in this post exemplifies the precision medicine in musculoskeletal practice: using anatomical knowledge, careful palpatory assessment, and provocation testing to target precisely the pathological tissue, preceded by meticulous aseptic technique to minimize procedural risks.

The rehabilitation program described across four progressive stages—from education and load management, through isometric and isotonic exercise, to functional reintegration and gait retraining—represents the current evidence-based standard of care for gluteus medius tendinopathy and provides the framework within which injection therapy, ESWT, and PRP are most effectively deployed. The importance of addressing systemic factors — including metabolic health, sleep, nutrition, and psychological well-being — as part of a truly comprehensive management approach has been underscored throughout.

Conclusion

The case of the 57-year-old gentleman presenting with a two-month history of left hip pain, examined and treated on September 15, 2026, exemplifies the remarkable complexity concealed within what might superficially appear to be a straightforward clinical presentation of “hip pain.” Accurate diagnosis, effective communication of its significance to the patient, and a management program that addresses not only the immediate symptom burden but also the underlying factors driving the degenerative process require a thorough understanding of the relevant anatomy, pathophysiology, biomechanics, and evidence base.

Evidence-based musculoskeletal medicine—integrating the best available research evidence with clinical expertise and the individual patient’s values and circumstances—is the highest standard to which clinicians in this field can aspire. Through ongoing education, regular engagement with the current literature, and a commitment to comprehensive, patient-centered care, we can consistently deliver outcomes for patients with gluteus medius tendinopathy that go beyond simple pain relief to genuine restoration of function, resilience, and quality of life.

I invite readers to explore additional clinical resources, case discussions, and evidence-based treatment protocols at HealthVoice360.com, where I continue to share clinical insights drawn from my dual practice as a Doctor of Chiropractic and a Family Nurse Practitioner-Advanced Practice Registered Nurse.

Key Insights

• Gluteus medius tendinopathy, not trochanteric bursitis, is the predominant pathology in most patients presenting with lateral hip pain and GTPS; accurate diagnosis requires specific palpatory provocation testing, orthopedic assessment, and imaging to confirm tendon involvement.
• Compressive loading of the gluteus medius tendon at its insertional site — driven by hip adduction postures, gait biomechanics, and body habitus — is the primary mechanical driver of insertional tendinopathy, and modification of compressive loads is the foundational first step in all treatment protocols.
• The tendinopathy continuum model (reactive ? dysrepair ? degenerative) provides a physiologically grounded framework for understanding why different patients respond differently to treatment and why interventions matched to the stage of pathology are more effective than one-size-fits-all approaches.
• Corticosteroid injection provides superior short-term pain relief but does not maintain this advantage at medium- and long-term follow-up compared to ESWT and exercise; injection is most effective when used as a facilitator of rehabilitation rather than a standalone treatment.
• Progressive tendon-loading exercise—particularly heavy slow resistance training progressed systematically through isometric, isotonic, and functional stages—is the cornerstone of long-term recovery from gluteus medius tendinopathy and should be included in every management program.
• Extracorporeal shockwave therapy delivers superior long-term outcomes compared to corticosteroid injection at 15-month follow-up, with a favorable safety profile and non-invasive delivery, making it a first-line option for chronic GTPS.
• Platelet-rich plasma injection is a rational, evidence-supported second-line option for refractory cases, delivering concentrated growth factors that may promote tendon matrix regeneration and repair in ways corticosteroids cannot.
• The multi-modal approach — combining patient education, load management, progressive exercise, targeted injection or ESWT, nutritional optimization, sleep improvement, and where indicated, psychological support — produces the best outcomes for complex or refractory cases and reflects the true complexity of tendinopathy as a biopsychosocial condition.
• Precise clinical diagnosis through systematic examination, including palpatory provocation testing and confirmation of pain reproduction, is the essential prerequisite for all targeted treatment and remains the most important skill in managing this condition.
• Patient education and aalliance are therapeuticanceare thown rightc in their ownrightc. Patients who understand their condition, the mechanism of their pain, and the rationale for their treatment program show better adherence, lower catastrophizing, and better long-term outcomes.

References

1. Cook JL, Purdam CR. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. British Journal of Sports Medicine. 2009;43(6):409–416.
2. Fearon AM, Scarvell JM, Cook JL, Smith PN. Does ultrasound correlate with surgical or histologic findings in greater trochanteric pain syndrome? A pilot study. Clinical Orthopedics and Related Research. 2010;468(7):1838–1844.
3. Grimaldi A, Fearon A. Gluteal tendinopathy: Integrating pathomechanics and clinical features in its management. Journal of Orthopedic & Sports Physical Therapy. 2015;45(11):910–922.
4. Connell DA, Bass C, Sykes CA, Young D, Edwards E. Sonographic evaluation of gluteus medius and minimus tendinopathy. European Radiology. 2003;13(6):1339–1347.
5. Lievense A, Bierma-Zeinstra S, Schouten B, Bohnen A, Verhaar J, Koes B. Prognosis of trochanteric pain in primary care. British Journal of General Practice. 2005;55(512):199–204.
6. Rompe JD, Segal NA, Cacchio A, Furia JP, Morral A, Maffulli N. Home training, local corticosteroid injection, or radial shock wave therapy for greater trochanter pain syndrome. American Journal of Sports Medicine. 2009;37(10):1981–1990.
7. Rio E, Kidgell D, Purdam C, et al. Isometric exercise induces analgesia and reduces inhibition in patellar tendinopathy. British Journal of Sports Medicine. 2015;49(19):1277–1283.
8. Woodley SJ, Nicholson HD, Livingstone V, et al. Lateral hip pain: Findings from magnetic resonance imaging and clinical examination. Journal of Orthopedic & Sports Physical Therapy. 2008;38(6):313–328.
9. Beyer R, Kongsgaard M, Hougs Kjær B, Øhlenschlæger T, Kjær M, Magnusson SP. Heavy slow resistance versus eccentric training as treatment for Achilles tendinopathy: A randomized controlled trial. American Journal of Sports Medicine. 2015;43(7):1704–1711.
10. Noehren B, Hamill J, Davis I. Prospective evidence for a hip etiology in patellofemoral pain. Medicine and Science in Sports and Exercise. 2013;45(6):1120–1124.
11. Shaw G, Lee-Barthel A, Ross ML, Wang B, Baar K. Vitamin C–enriched gelatin supplementation before intermittent activity augments collagen synthesis. American Journal of Clinical Nutrition. 2017;105(1):136–143.
12. Alfredson H, Ohberg L. Neovascularisation in chronic painful patellar tendinosis — promising results after sclerosing neovessels outside the tendon challenge the need for surgery. Knee Surgery, Sports Traumatology, Arthroscopy. 2005;13(2):74–80.
13. Fitzpatrick J, Bulsara MK, O’Donnell J, Zheng MH. Leucocyte-rich platelet-rich plasma treatment of gluteus medius and minimus tendinopathy: A double-masked randomized controlled trial with 2-year follow-up. American Journal of Sports Medicine. 2019;47(5):1130–1137.
14. Mellor R, Bennell K, Grimaldi A, et al. Education plus exercise versus corticosteroid injection use versus a wait-and-see approach on global outcome and pain from gluteal tendinopathy: Prospective, single-blinded, randomized clinical trial. BMJ. 2018;361:k1662.
15. Segal NA, Felson DT, Torner JC, et al. Greater trochanteric pain syndrome: Epidemiology and associated factors. Archives of Physical Medicine and Rehabilitation. 2007;88(8):988–992.
16. Cook JL, Rio E, Purdam CR, Docking SI. Revisiting the continuum model of tendon pathology: What is its merit in clinical practice and research? British Journal of Sports Medicine. 2016;50(19):1187–1191.
17. Docking SI, Cook J. Pathological tendons maintain sufficient aligned fibrillar structure on ultrasound tissue characterization (UTC). Scandinavian Journal of Medicine & Science in Sports. 2016;26(6):675–683.
18. Grimaldi A, Mellor R, Hodges P, Bennell K, Wajswelner H, Vicenzino B. Gluteal tendinopathy: A review of mechanisms, assessment and management. Sports Medicine. 2015;45(8):1107–1119.
19. Rio E, Moseley L, Purdam C, et al. The pain of tendinopathy: Physiological or pathophysiological? Sports Medicine. 2014;44(1):9–23.
20. Lutz GE, Simone DA, Bhargava MM. Acute effect of corticosteroids on tendon cells in vitro. Journal of Orthopedic Research. 1990;8(4):577–583.

Keywords

gluteus medius tendinopathy, greater trochanteric pain syndrome, lateral hip pain, trochanteric bursitis, hip abductor tendon, peritendinous injection, corticosteroid injection, ultrasound-guided injection, tendinopathy rehabilitation, eccentric exercise, heavy slow resistance training, extracorporeal shockwave therapy, platelet-rich plasma, hip biomechanics, Trendelenburg gait, compressive tendinopathy, musculoskeletal ultrasound, MRI tendinopathy, pain neuroscience, central sensitization, gluteal tendinopathy, chiropractic hip treatment, functional movement assessment, collagen synthesis, tenocyte biology, isometric exercise analgesia, hip abductor strengthening, gait retraining, HealthVoice360, Dr. Alexander Jimenez DC FNP

Medical Disclaimer: The information presented in this educational post is intended solely for general educational and informational purposes. It does not constitute, and should not be interpreted as, medical advice, medical diagnosis, or a recommended treatment plan for any individual. The clinical case discussed is an educational illustration of assessment and treatment principles. It is not intended to represent a universally applicable protocol for all patients with similar symptoms.

All individuals experiencing pain, functional limitation, or any musculoskeletal concern are strongly advised to seek evaluation and personalized recommendations from a qualified, licensed healthcare provider familiar with their complete medical history, current health status, medications, and individual circumstances. No information contained in this post should be used as the basis for self-diagnosis or self-treatment.

The clinical observations and treatment approaches described reflect the professional practice and perspective of Dr. Alexander Jimenez, DC, FNP-APRN, FNP-BC, as presented through HealthVoice360.com, and are not intended to establish a standard of care or to supersede the individualized judgment of treating clinicians.

All individuals must obtain recommendations for their personal situations from their own qualified medical providers.